Trial Profile
Metabolic Effects of Antipsychotic Substitution in Children.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II/III
Latest Information Update: 08 May 2014
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Olanzapine (Primary) ; Risperidone (Primary)
- Indications Affective disorders; Anxiety disorders; Asperger syndrome; Attention deficit and disruptive behaviour disorders; Autistic disorder; Bipolar disorders; Conduct disorder; Depressive disorders; Generalised anxiety disorder; Gilles de la Tourette's syndrome; Major depressive disorder; Mood disorders; Movement disorders; Obsessive-compulsive disorders; Pervasive child development disorders; Psychotic disorders; Schizophrenia; Social phobia; Tic disorders
- Focus Adverse reactions
- Acronyms SMEAC
- 20 Nov 2009 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov
- 06 Jun 2009 New trial record